Alex Dorosheva is an associate attorney focusing her practice on preparation and prosecution of US and foreign patent applications in the fields of life science, biotechnology, and pharmaceuticals. Alex has experience in patent application drafting and prosecution, global portfolio review and management, and prior art review including patentability analysis, landscape analysis, freedom-to-operate analysis.

​

Alex received her B.S. in Biochemistry from Rider University, Ph.D. in Pharmaceutical Sciences from University of North Carolina at Chapel Hill, and J.D. from Temple University. Prior to working in intellectual property law, Alex worked as a scientific researcher. She has extensive research experience in the fields of biochemistry and protein engineering, cell and molecular biology, biopharmaceuticals, cell and gene therapy, and oncology. Alex’s dissertation work focused on developing a novel protein-decoy inhibitor for targeting an oncogenic pathway in uveal melanoma and utilizing gene therapy-based approaches (DNA/mRNA nanodelivery systems, and AAV) for intracellular delivery for potential treatment development. Alex has co-authored several scientific publications spanning a wide variety of topics, including lipid signaling, protein engineering, cancer therapies/immunotherapies, gene therapies, nanotechnology and drug delivery.